Back to search
FDAFDA · Food and drugs·Recall number Z-2809-2026

EOPA Elongated One-Piece Arterial Cannula DIL TIP 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 77722

Published August 5, 2026 · Recall initiated: June 24, 2026

Summary

FDA records medical device Class II recall Z-2809-2026, published August 5, 2026 and initiated June 24, 2026. Recalling firm: Medtronic Perfusion Systems; Status: Ongoing; Reported quantity: 3,110 units; Lot: UDI-DI: 20199150023312, Lot Numbers: 0232657469 0232670800 0232744945 0232798410 0232862769 0232985251 0233116924 0233116931; UDI-DI: 00199150023318, Lot Numbers: 0232744945. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Pinhole leaks may occur in the wire-wound body during cardiopulmonary bypass. Potential risks associated with this condition may include hypovolemia, vessel laceration or perforation, hypotension, ischemia, and organ dysfunction.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medtronic Perfusion Systems
Distributor
Worldwide - US Nationwide distribution.
Lot
UDI-DI: 20199150023312, Lot Numbers: 0232657469 0232670800 0232744945 0232798410 0232862769 0232985251 0233116924 0233116931; UDI-DI: 00199150023318, Lot Numbers: 0232744945
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was EOPA Elongated One-Piece Arterial Cannula DIL TIP 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 77722 recalled?

Yes. FDA published recall Z-2809-2026 on August 5, 2026. Reported hazard: Pinhole leaks may occur in the wire-wound body during cardiopulmonary bypass. Potential risks associated with this condition may include hypovolemia, vessel laceration or perforation, hypotension, ischemia, and organ dysfunction.

What should I do if I have this product?

Voluntary: Firm initiated · Letter